4DQE - Sequence, Chains, Asymmetric and Biological Units

• Title: CRYSTAL STRUCTURE OF (G16C/L38C) HIV-1 PROTEASE IN COMPLEX W
• Keywords: HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIB AIDS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	4DQE	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	ASPARTYL PROTEASE	A	99	734	0
2	Protein	ASPARTYL PROTEASE	B	99	739	0
3	Ligand	ASPARTYL PROTEASE	B	2	0	42
4	Water			133	0	133
total				333	1473	175

Proteins

Unit 1

PRO 1 GLN 2 ILE 3 THR 4 LEU 5 TRP 6 LYS 7 ARG 8 PRO 9 LEU 10 VAL 11 THR 12 ILE 13 ARG 14 ILE 15 CYS 16 GLY 17 GLN 18 LEU 19 LYS 20 GLU 21 ALA 22 LEU 23 LEU 24 ASP 25 THR 26 GLY 27 ALA 28 ASP 29 ASP 30 THR 31 VAL 32 ILE 33 GLU 34 GLU 35 MET 36 ASN 37 CYS 38 PRO 39 GLY 40 LYS 41 TRP 42 LYS 43 PRO 44 LYS 45 MET 46 ILE 47 GLY 48 GLY 49 ILE 50 GLY 51 GLY 52 PHE 53 ILE 54 LYS 55 VAL 56 ARG 57 GLN 58 TYR 59 ASP 60 GLN 61 ILE 62 ILE 63 ILE 64 GLU 65 ILE 66 ALA 67 GLY 68 HIS 69 LYS 70 ALA 71 ILE 72 GLY 73 THR 74 VAL 75 LEU 76 VAL 77 GLY 78 PRO 79 THR 80 PRO 81 VAL 82 ASN 83 ILE 84 ILE 85 GLY 86 ARG 87 ASN 88 LEU 89 LEU 90 THR 91 GLN 92 ILE 93 GLY 94 ALA 95 THR 96 LEU 97 ASN 98 PHE 99

Unit 2

PRO 1 GLN 2 ILE 3 THR 4 LEU 5 TRP 6 LYS 7 ARG 8 PRO 9 LEU 10 VAL 11 THR 12 ILE 13 ARG 14 ILE 15 CYS 16 GLY 17 GLN 18 LEU 19 LYS 20 GLU 21 ALA 22 LEU 23 LEU 24 ASP 25 THR 26 GLY 27 ALA 28 ASP 29 ASP 30 THR 31 VAL 32 ILE 33 GLU 34 GLU 35 MET 36 ASN 37 CYS 38 PRO 39 GLY 40 LYS 41 TRP 42 LYS 43 PRO 44 LYS 45 MET 46 ILE 47 GLY 48 GLY 49 ILE 50 GLY 51 GLY 52 PHE 53 ILE 54 LYS 55 VAL 56 ARG 57 GLN 58 TYR 59 ASP 60 GLN 61 ILE 62 ILE 63 ILE 64 GLU 65 ILE 66 ALA 67 GLY 68 HIS 69 LYS 70 ALA 71 ILE 72 GLY 73 THR 74 VAL 75 LEU 76 VAL 77 GLY 78 PRO 79 THR 80 PRO 81 VAL 82 ASN 83 ILE 84 ILE 85 GLY 86 ARG 87 ASN 88 LEU 89 LEU 90 THR 91 GLN 92 ILE 93 GLY 94 ALA 95 THR 96 LEU 97 ASN 98 PHE 99

Ligands

Unit 3

017 101 ACT 102